Global Portable Ultrasound Device Market Expected to Grow at 8.8% CAGR During 2016 – 2022

The global portable ultrasound device market was valued at $1,392.8 million in 2015, and it is expected to grow at a CAGR of 8.8% during 2016-2022. Based on type, the hand held segment is expected to witness the faster growth, CAGR 13.1%, during the forecast period.

The global portable ultrasound device market is growing at a significant rate, due to increasing healthcare expenditure, and growing geriatric population. The increasing prevalence of chronic diseases and improving healthcare infrastructure in developing countries are also driving the growth of the global portable ultrasound device market. However, the factor such as stringent regulatory requirements for the approval of portable ultrasound devices is inhibiting the growth of the global market.

Ultrasound is a sound with frequencies higher than about 20 kHz. It moves in a wavelike manner through which it travels. The waves travel with different speed in different medium. The medical ultrasound system operates at higher frequencies, typically 1-10 MHz. The ultrasound machine calculates the distance from probe to the tissue or organ, using the speed of the sound in the tissue and the time of the each echo returns. Portable ultrasound device is mainly used at point-of-care, as they are convenient to carry and are lighter and smaller.

Explore the Potentials of “Global Portable Ultrasound Device Market” at: https://www.psmarketresearch.com/market-analysis/portable-ultrasound-device-market

Geographically, Europe dominated the global market of portable ultrasound device in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, at a CAGR of 9.5%, during the forecast period.

Some of the key companies operating in the global portable ultrasound device market include Koninklijke Philips N.V., General Electric Company, Hitachi Ltd., Siemens AG, and FUJIFILM Holdings Corporation.

Beauty Devices Market Analysis, Size, Development and Forecast to 2022

The global beauty devices market was valued at $23,403.9 million in 2015, and it is expected to grow with a CAGR of 19.0% during the period 2016 - 2022. The market is growing, due to the growth of the geriatric population and increasing prevalence of skin diseases, such as acne and psoriasis. In addition, the increase in disposable income is leading to increase in spending on personal care, thus boosting the growth of the global beauty devices market.

Among the various types of beauty devices, the Light/LED therapy and photorejuvenation devices is expected to witness the fastest growth during the forecast period. Based on applications of beauty devices, the salon segment had the largest market size in 2015; however, the at home segment is expected to witness the fastest growth during the forecast period.

Explore Full Report on “Global Beauty Devices Market” at: https://www.psmarketresearch.com/market-analysis/beauty-devices-market

The growth of hair and skin problems as a result of pollution and exposure to U.V. radiation leads to photo aging of skin, sunburns, less collagen built up, reduction of skin elasticity, and also hair loss. Skin diseases are also caused by other factors, such as environmental pollution, excessive alcohol consumption, and tobacco use. Cases with skin diseases are also increasing due to infections caused by viruses, bacteria, and fungi.

The aging population acts as a major driver for the global beauty devices market, as old age is associated with loss of fibrous tissue and a reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered, thus leading to wrinkles, dryness, pigmentary alteration, and sagging of the skin. The anti-aging products and devices help in reducing skin aging, giving a person a younger look by revitalizing and tightening the skin; hence, fuelling the demand for beauty devices globally.

Request For Sample Pages: https://www.psmarketresearch.com/market-analysis/beauty-devices-market/report-sample

However, the side effects associated with the usage of these devices, such as superficial burns, scarring, edema, postoperative erythema, and ecchymosis; and the risks associated with photorejuvenation devices including discomfort, excessive swelling, fragile skin, bruising, and blistering, acts as major restraints for the growth of the beauty devices market.

Some of the key companies operating in the beauty devices market include L'Oréal Group, Nu Skin Enterprises Inc., Panasonic Corporation, Home Skinovations Ltd., PhotoMedex Inc., Carol Cole Company, Procter & Gamble Company, Syneron Medical Ltd., TRIA Beauty Inc., and Koninklijke Philips N.V.

Molecular Biology Kits and Reagents and Enzymes Market Trends, Size, Share, Growth and Forecast to 2022

The global molecular biology kits and reagents and enzymes market was valued at $4,928.3 million in 2015 and it is expected to grow at a CAGR of 17.2% during 2016 - 2022. The molecular biology kits and reagents and enzymes market is growing due to increasing geriatric population, increasing prevalence of infectious diseases, and growing cases with genetic disorders. In addition, increasing healthcare expenditure resulting in improvement in research activities is further driving the market growth.

Based on product, kits and reagents accounted for the largest market in the global market in 2015, and it is expected to witness 17.7% CAGR during 2016 – 2022. Among the various applications, sequencing segment is expected to witness the fastest growth during the forecast period. Whereas, among and user user hospital segment is expected to witness the fastest growth during the forecast period.

Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market

Geographically, North America has been globally the largest market of molecular biology kits and reagents and enzymes, owing to the improvement in research and development activities and increasing cases with genetic disorders in the region. Furthermore, increase in number of pharmaceutical and biotechnology companies are also driving the market growth in this region. However, the molecular biology kits and reagents and enzymes market is expected to witness fastest growth in Asia-Pacific, with a CAGR of 17.8% during the forecast period. The high growth is attributed to increasing awareness about molecular biology kits and reagents and enzymes and increasing cases with molecular diagnostics in the region.

Molecular biology kits and reagents and enzymes helps in detecting specific sequences in DNA or RNA. In addition, they help in detection of infectious diseases, genetic disease screening, human leukocyte antigen typing, extraction and purification of nucleic acid and detection of amplified nucleic acid. However, the high cost of molecular biology kits and reagents and enzymes as well the privacy issues related to genetic information act as the key restraints in the growth of the market. High cost of these kits and reagents and enzymes limits the affordability of the users, and hampering the growth of the market.

Browse Related Report at: https://www.psmarketresearch.com/industry-report/healthcare

Some of the competitors in the global molecular biology kits & reagents and enzymes market are Thermo Fisher Scientific, Inc., Merck KGAA, Qiagen N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Promega Corporation, New England Biolabs, Inc., Illumina, Inc. and Takara Bio Inc.

Smart Home Healthcare Market Trends, Size, Share, Development and Forecast to 2022

The global smart home healthcare market is expected to grow with a CAGR of 38% during 2016 - 2022. Among the various applications, the fall prevention and detection segment is expected to witness the fastest growth during the forecast period. The global smart home healthcare market is growing at a significant rate, due to growing demand for advanced smart home healthcare technologies, and growing geriatric population. In addition, the increasing demand of mobile health (mHealth) technologies, and increasing demand of personalized healthcare technologies are also driving the growth of the global smart home healthcare market.

Explore Report with Detailed TOC on “Global Smart Home Healthcare Market” at: https://www.psmarketresearch.com/market-analysis/smart-home-healthcare-market

Smart home is a home monitoring and control system, which helps in the monitoring of home when the resident away, and also simplifies the switching appliances on and off automatically. The smart homes have the ability to monitor and control home from the convenience of smartphone or tablets.

Request for Sample Pages: https://www.psmarketresearch.com/market-analysis/smart-home-healthcare-market/report-sample

In the healthcare sector, the smart home technology is combined with innovative and advanced monitoring technologies that are designed to detect health status changes. Moreover, the combination of smart home technology with healthcare technology is likely to be an effective approach to prevent nursing home placement for frail older adults.

The factors, such as privacy and security issues, and high capital expenditure are inhibiting the growth of the global market. The growing popularity of IoT devices in the home healthcare sector is the major trend witnessed in the smart home healthcare market.

Browse Related Research: https://www.psmarketresearch.com/industry-report/healthcare

Geographically, North America dominated the global market of smart home healthcare market in 2015; whereas the Asian market is expected to witness the fastest growth at a during the forecast period.

Some of the key companies operating in the global smart home healthcare market include AT&T Inc., ABB Ltd, Siemens AG, Schneider Electric SE, General Electric Company, Honeywell Life Care Solutions, Smart Solutions, Essence Group, and Koninklijke Philips N.V.

Next-Generation Antibody Therapeutics Market Analysis, Size, Development and Forecast to 2020

The global next generation antibody therapeutics market was valued at $1,328.3 million in 2014 and it is expected to grow at a CAGR of about 44% during the period 2015 - 2020. The global next-generation antibody therapeutics market is growing due to increasing popularity of antibody-drug conjugate (ADC) and increasing number of collaborations for R&D in next-generation antibody therapeutics. In addition, growing prevalence of chronic diseases and increase in research and development investments by various organizations for production of improved products further encourages the growth of global next-generation antibody therapeutics market. Furthermore, increase in healthcare expenditure and technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, which is resulting in increased demand for next-generation antibody therapeutics.

Explore Report Description with Detailed ToC on “Global Next-Generation Antibody Therapeutics Market” at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market

Based on technology, the Fc Engineered Antibodies market is expected to witness the highest growth (CAGR of 11%) during the forecast period. Among the therapeutic areas, the oncology segment led the global next-generation antibody therapeutics market in 2014, with the largest market size, but the autoimmune/inflammatory is expected to see the fastest growth of 46.4% CAGR, during the period 2015 – 2020.

Browse Related Research at: https://www.psmarketresearch.com/industry-report/healthcare

However, certain restraints such as high cost of next-generation antibody therapeutics, stringent regulatory requirements and time-consuming approval process for new drugs are hindering the market growth. North America next-generation antibody therapeutics market is expected to witness the fastest growth of CAGR 46.2% globally, during the period 2015 – 2020.

The key companies operating in the global next-generation antibody therapeutics market include Seattle Genetics Inc., F. Hoffmann-La Roche Ltd, ImmunoGen Inc., Pfizer Inc., Amgen Inc., Biogen, Kyowa Hakko Kirin Co. Ltd., Bristol-Myers Squibb Company, Xencor Inc., AstraZeneca PLC., Dyax Corp., Takeda Pharmaceuticals Company Limited and Bayer AG.

Global Wood Vinegar Market Analysis, Size, Share, Growth and Forecast to 2023

The global wood vinegar market was valued at $3.2 million in 2015, and it is expected to grow at a CAGR of 7.1% during 2016-2023. The factors driving the growth of the global market include improved crop yield, increasing base of end-use industries, increased government initiatives for bio-based products, and stringent environmental regulations. The key trend witnessed in the global market is poverty alleviation. Wood vinegar can be produced at either small scale or large scale in villages, utilizing local resources and feedstock. Wood vinegar production is helping to reduce poverty in several developing or underdeveloped countries. The global wood vinegar market is at its nascent form. Currently, very few players across the globe are involved in large scale production of wood vinegar. However, the distinct governments and organizations in several countries across the globe are framing regulations for bio-based economy and promoting bio-based products, which are supporting the growth of biochar production and biorefineries. As wood vinegar is a byproduct of char or biochar production, the government initiatives indirectly creates abundant opportunities for the growth of the wood vinegar market globally.

Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/wood-vinegar-market

Based on application, the agriculture segment dominated the global wood vinegar market during 2013-2015 in terms of value and volume, and it is expected to retain its dominance throughout the forecast period. The growth of agriculture application segment in the market is primarily driven by several advantages offered by wood vinegar in agricultural practices, such as root growth stimulation, improved seed germination, increased disease resistance in plants, and soil enrichment.

In 2015, Asia-Pacific held the largest share in the global wood vinegar market. The major reasons behind the growth of the market in the region are the large base of end-use industries and presence of a large number of local manufacturers in the region.

Browse Related Market Research Reports at: https://www.psmarketresearch.com/industry-report/consumer-products

Some of the major players operating in the global wood vinegar market are Ace (Singapore) Pte Ltd., TAGROW CO. LTD., Byron Biochar, Canada Renewable Bioenergy Corporation, NAKASHIMA TRADING CO. LTD., Nettenergy B.V., and Taiko Pharmaceutical Co. Ltd.

Vitamin Supplements Market Analysis, Size, Development and Demand Forecast to 2020

The global vitamin supplements market, estimated to be valued at $36,929 million in 2014, is expected to grow at 6.5% CAGR during 2014 to 2020, mainly attributed to growing consciousness among consumer about preventative healthcare. Healthcare spend is increasing with the increasing research and development (R&D) expenditure. Due to the increasing cost of healthcare, people are turning towards supplement products, including vitamin supplements, for a healthy life. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA) member associations, the European pharmaceutical R&D expenditure increased from $37,030 million in 2011 to $38,055 million in 2012. In the U.S., the expenditure increased from $36,374 million in 2011 to $36,810 million in 2012. Asia-Pacific holds a major market share in the global vitamin supplements market, followed by North America and Europe. Asia-Pacific is expected to dominate the market in the forecast period owing to increasing geriatric population.

Explore detailed TOC and Scope of the report: https://www.psmarketresearch.com/market-analysis/vitamin-supplements-market

Deficiency of vitamin in body at older age increases the risk of diseases, such as night blindness, diminishing eyesight, fragile bones and mental disorders. This requires more nutrient-rich foods at older age. It is important to maintain balance of nutrients, including vitamin, to keep the body functioning properly. These deficiencies can be fulfilled by consuming additional supplement products. Vitamin supplement is one among the majorly consumed supplements products at later age. People aged 65 years and above are not much exposed to sun, one of the major source of vitamin D.

The healthcare industry leads the global vitamins supplements market accounting for more than one third of global market share. The vitamin supplements in healthcare industry is estimated to account $17,950 million in 2014 and it is expected to grow at 6.4% CAGR during 2014 to 2020. Increasing expenditure on research and development conducted by healthcare industry is expected to increase the overall healthcare cost globally. Due to the increasing cost of healthcare, people are turning towards supplement products including vitamin supplements, as it provides various health benefits, such as proper functioning of immune system (vitamin C), strengthening to bone and joints (vitamin D), and improving vision power (vitamin A).

Browse More Reports on Consumer Products: https://www.psmarketresearch.com/industry-report/consumer-products

The vitamin supplements market is highly fragmented with large number of multinational and regional players operating in the market, who distribute their products locally as well as internationally. Some of the major competitors in the global vitamin supplements market include Glanbia plc, NBTY, Inc., Reckitt Benckiser Group plc, Archer Daniels Midland Company, E.I. du Pont de Nemours and Company, Royal DSM N.V., BASF SE, Integrated BioPharma Inc, Bayer AG, Pharmavite LLC, Nutraceutical International Corporation, Herbalife Ltd.

Patient Handling Equipment Market, Size, Share, Development and Forecast to 2022

The global patient handling equipment market was valued at $9,515.9 million in 2015 and it is expected to grow at a CAGR of 10.5% during 2016-2022. Among the various end users of patient handling equipment, the home healthcare segment is expected to witness the fastest growth, a CAGR of 11.0% during the forecast period.

The global patient handling equipment market is growing at a significant rate due to increasing healthcare expenditure, increasing risk of injuries to caregivers during patient handling and growing geriatric population. The increasing prevalence of chronic diseases and advancements in technology has led to the development of easy to handle and powered patient handling equipment. And the improving healthcare infrastructure in developing countries are also driving the growth of the global patient handling equipment market.

Explore Full Report on “Global Patient Handling Equipment Market” at: https://www.psmarketresearch.com/market-analysis/patient-handling-equipment-market

Patient handling equipment are equipment used for safely moving or supporting a patient or any of his body part. The equipment improves working conditions of caregivers by reducing biomechanical overload risk, work-related injury and requires high amount of care and skill technique. In addition, the equipment improves quality of patient care and account for patient safety. The factors such as lack of training provided to caregivers for efficient operation of equipment and difficulty in handling bariatric patients are inhibiting the growth of the global market.

Geographically, Europe dominated the global market of patient handling equipment in 2015; whereas the North American market is expected to witness the fastest growth, a CAGR of 11.0% during the forecast period. This is due to the high awareness among caregivers for safe patient handling and stringent regulations in the region.

Browse Related Research: https://www.psmarketresearch.com/industry-report/medical-devices

Some of the key companies operating in the global patient handling equipment market include Stryker Corporation, Hill-Rom Holdings Inc., Invacare Corporation, Getinge Group, Prism Medical Ltd., Guldmann Inc., LINET Group SE, Joerns Healthcare LLC, Stiegelmeyer-Group, and Handicare.

Global mHealth Market, Insight, Size, Development and Demand Forecast to 2022

The global mHealth market was valued at $13,674.3 million in 2015, and it is expected to grow at a CAGR of 34.0% during 2016 - 2022. Among the various products and services, the mHealth application segment is expected to witness the fastest growth, at a CAGR of 40.1%, during the forecast period. The global mhealth market is growing at a significant rate, due to increasing healthcare cost, increasing demand for patient centric healthcare model, and increasing prevalence of chronic and lifestyle associated diseases. In addition, the growing demand for mhealth technologies, increasing access of mobile platforms, tablets and smartphones, increasing utilization of connected medical devices and mhealth applications, and growing need for remote patient monitoring services are also driving the growth of the global mhealth market.

Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/mobile-healthcare-market

Mobile health (mHealth) is the use of mobile information and communication technologies for improving healthcare. It helps to tackle major challenges faced by the healthcare industry such as regulatory changes, continuous remote monitoring at home, increasing demand for quality healthcare, increasing error occurrence and integration with existing IT systems.

Factors, such as lack of data security and privacy, and insufficient memory, computational, and energy limitations are inhibiting the growth of the global market. The increasing number of collaborations and partnerships, growing number of product launches and approvals, and increasing demand for cloud technology in healthcare are the key trends observed in the global mhealth market.

Browse Related Research at: https://www.psmarketresearch.com/industry-report/medical-devices

Some of the key companies operating in the global mhealth market include LifeWatch AG, Cisco Systems Inc., Cerner Corporation, OMRON Corporation, AT&T Inc., athenahealth Inc., Airstrip Technologies Inc., AliveCor Inc., AgaMatrix Inc., iHealth Labs Inc., Koninklijke Philips N.V., BioTelemetry Inc., Medtronic PLC, Withings SAS, and Johnson & Johnson.